查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1784825

全球兽医支架市场

Veterinary Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 235 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球兽医支架市场规模将达到 7,570 万美元

全球兽用支架市场规模预计在2024年为5,220万美元，预计2030年将达到7,570万美元，2024年至2030年的复合年增长率为6.4%。气道支架是本报告分析的细分市场之一，预计其复合年增长率为7.9%，到分析期结束时将达到3,900万美元。尿道支架市场在分析期间的复合年增长率预计为4.4%。

美国市场规模估计为 1,370 万美元，中国市场预计复合年增长率为 6.2%

美国兽医支架市场规模预计2024年达到1,370万美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到1,210万美元，在分析期间（2024-2030年）的复合年增长率为6.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为6.1%和5.3%。在欧洲，预计德国的复合年增长率为5.0%。

全球兽医支架市场－主要趋势与驱动因素摘要

为什么兽用支架在动物保健中变得至关重要？

兽用支架已成为治疗各种动物疾病的重要工具，包括气管塌陷、尿道阻塞、心血管异常和胆道阻塞。随着兽药的进步，支架置入已成为传统外科手术的微创替代方案，为先前需要大量且有风险的手术才能治疗的疾病提供长期缓解。气管塌陷在约克夏犬和博美犬等小型犬中特别常见，这是采用支架的主要原因，因为支架可以立即打开气道并改善呼吸。同样，尿道和胆道支架彻底改变了伴侣动物和牲畜阻塞性疾病的治疗方法，使阻塞通道能够长期通畅。兽医心臟病学也受惠于支架置入术，特别是在治疗肺动脉狭窄等先天性心臟疾病。随着微创技术的重视，兽医支架可以减少恢復时间和手术风险，在现代兽医学中发挥越来越重要的作用，改善了患有复杂疾病的动物的生活品质。

动物支架技术有哪些最新进展？

兽用支架市场已取得重大技术进步，提高了这些器械的安全性、耐用性和有效性。其中最显着的创新之一是自膨式镍钛合金支架的开发，这种支架可顺应解剖结构，无需手术干预。其灵活的特性降低了移位风险，并最大限度地减少了与硬质支架相关的併发症。生物分解性支架也已成为一种有前途的选择，特别是对于不需要长期放置支架的临时干预措施。此外，药物释放型支架的进展正在改善术后结果，这种支架可以缓慢释放药物以防止发炎和血管再阻塞。根据特定动物解剖结构定制的支架越来越受欢迎，特别是在气管和尿道应用中，可确保更好的贴合併减少不适。使用萤光透视和内视镜引导放置支架进一步提高了精度，使兽医能够微创放置支架。随着生物材料和兽医介入放射学研究的不断发展，支架在兽医应用中的有效性和多功能性预计将显着扩大。

阻碍兽用支架广泛使用的挑战有哪些？

儘管兽用支架的有效性已得到证实，但仍有几个挑战阻碍了其广泛应用。一个主要障碍是支架置入术的高成本，包括支架本身、专门的成像设备以及正确插入所需的专业知识。许多兽医院和诊所缺乏必要的介入放射学基础设施，导致支架置入术只能在设备齐全的专科中心进行。此外，虽然支架可以立即缓解阻塞，但支架移位、阻塞和组织长出等长期併发症仍然是一个问题，需要持续监测，在某些情况下还需要额外的干预。另一个挑战是缺乏标准化的兽用支架尺寸，因为大多数用于动物的支架都是从人类支架改装而来的，并且并不总是提供理想的解剖贴合。与支架置入术相关的学习曲线也限制了其应用，因为需要专门的训练才能确保支架置入成功和术后管理。应对这些挑战需要进一步研究兽医专用支架设计、增加兽医的培训机会以及在兽医医院更广泛地提供介入放射学服务。

兽医支架市场的主要成长动力是什么？

兽用支架市场的成长受到多种因素的推动，包括介入兽医学的进步、宠物饲养量的增加以及对微创治疗方案日益增长的需求。随着越来越多的宠物饲主为他们的宠物寻求先进的医疗护理，他们对能够缩短康復时间并改善治疗效果的非手术解决方案的兴趣日益浓厚。兽医循环系统和肺病学领域的不断发展，大大促进了对气管和血管支架的需求，尤其是在治疗先天性疾病和老龄化性疾病方面。此外，伴侣动物和家畜泌尿道疾病和阻塞的盛行率不断上升，也推动了对尿道和胆道支架的需求。影像处理和支架材料的技术创新也使这些手术更加安全有效，进一步推动了市场应用。配备介入放射学设施的兽医诊所数量不断增加，使得支架置入更加便捷，为更广泛的患者群体提供了更多治疗选择。随着兽医学继续转向侵入性更小、更方便患者的治疗方法，随着支架设计和技术的不断改进提高长期成功率，动物支架市场预计将经历显着增长。

部分

产品类型（气道支架、尿道支架、血管支架、其他支架）、动物类型（狗、猫、其他）、材料（镍钛合金、生物分解性聚合物）、应用（气道阻塞、尿道阻塞、血管阻塞、其他应用）、最终用途（兽医医院和诊所、其他）

受访公司范例

  • AccuPath Group Co., Ltd.
  • AbtVet（Stening Group）
  • Alibaba Group Holding Ltd.
  • Arthrex Vet Systems
  • Create Medic Co., Ltd.
  • Dextronix Animal Health
  • Infiniti Medical
  • MI Tech Co., Ltd.
  • NuMED For Children
  • TaeWoong Medical USA（VetSarang）
  • UltraVet Medical Devices LLC
  • VCA Animal Hospitals
  • VetMedUSA
  • VetStent
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP33271

Global Veterinary Stents Market to Reach US$75.7 Million by 2030

The global market for Veterinary Stents estimated at US$52.2 Million in the year 2024, is expected to reach US$75.7 Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Airway Stents, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$39.0 Million by the end of the analysis period. Growth in the Urethral Stents segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$13.7 Million While China is Forecast to Grow at 6.2% CAGR

The Veterinary Stents market in the U.S. is estimated at US$13.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.1 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Veterinary Stents Market - Key Trends & Drivers Summarized

Why Are Veterinary Stents Becoming Essential in Animal Healthcare?

Veterinary stents have emerged as a vital tool in treating a wide range of conditions, including tracheal collapse, urethral obstruction, cardiovascular anomalies, and biliary duct obstructions in animals. As veterinary medicine advances, stent placement has become a minimally invasive alternative to traditional surgical interventions, providing long-term relief for conditions that previously required extensive and high-risk procedures. Tracheal collapse, particularly common in small dog breeds such as Yorkshire Terriers and Pomeranians, has been a significant driver for the adoption of stents, as they provide immediate airway support and improve breathing. Similarly, urethral and biliary stents have transformed the treatment of obstructive diseases in both companion animals and livestock, allowing for prolonged patency of blocked passages. Veterinary cardiology has also benefited from stenting procedures, particularly in treating congenital heart defects such as pulmonic stenosis. With the growing emphasis on minimally invasive techniques that reduce recovery times and procedural risks, veterinary stents are playing an increasingly important role in modern animal healthcare, offering improved quality of life for animals suffering from complex medical conditions.

What Are the Latest Advancements in Veterinary Stent Technology?

The veterinary stents market has seen significant technological advancements, enhancing the safety, durability, and efficacy of these devices. One of the most notable innovations is the development of self-expanding nitinol stents, which conform to anatomical structures without requiring surgical intervention. These stents provide superior flexibility, reducing the risk of migration and minimizing complications associated with rigid stents. Biodegradable stents are also emerging as a promising alternative, particularly for temporary interventions where long-term stenting may not be necessary. Additionally, advancements in drug-eluting stents, which slowly release medication to prevent inflammation and restenosis, are improving post-procedural outcomes. Custom-designed stents tailored to specific animal anatomies are gaining traction, particularly for tracheal and urethral applications, ensuring a better fit and reducing discomfort. The use of fluoroscopic and endoscopic guidance for stent placement has further improved precision, allowing veterinarians to position stents with minimal invasiveness. As research in biomaterials and veterinary interventional radiology continues to evolve, the effectiveness and versatility of stents in veterinary applications are expected to expand significantly.

What Challenges Are Hindering the Widespread Adoption of Veterinary Stents?

Despite their proven efficacy, several challenges are limiting the widespread adoption of veterinary stents. One of the primary barriers is the high cost associated with stent placement procedures, including the stent itself, specialized imaging equipment, and the expertise required for proper insertion. Many veterinary clinics and hospitals lack the necessary interventional radiology infrastructure, restricting access to stenting procedures to only well-equipped specialty centers. Additionally, while stents offer immediate relief for obstructive conditions, long-term complications such as stent migration, occlusion, and tissue in-growth remain concerns that require continuous monitoring and, in some cases, additional interventions. Another challenge is the lack of standardized veterinary stent sizes, as most stents used in animals are adaptations of human stents, which may not always provide an ideal anatomical fit. The learning curve associated with stenting procedures also limits adoption, as specialized training is required to ensure successful placement and post-operative management. Addressing these challenges will require further research into veterinary-specific stent designs, increased training opportunities for veterinarians, and broader availability of interventional radiology services in veterinary hospitals.

What Are the Key Growth Drivers of the Veterinary Stents Market?

The growth in the veterinary stents market is driven by several factors, including advancements in interventional veterinary medicine, increasing pet ownership, and the rising demand for minimally invasive treatment options. As more pet owners seek advanced medical care for their animals, there is growing interest in non-surgical solutions that offer shorter recovery times and improved outcomes. The expanding field of veterinary cardiology and pulmonology has significantly contributed to the demand for tracheal and vascular stents, particularly for treating congenital and age-related conditions. Additionally, the rising prevalence of urinary tract diseases and obstructions in both companion animals and livestock has fueled the need for urethral and biliary stents. Technological innovations in imaging and stent materials have also made these procedures safer and more effective, further driving market adoption. The increasing number of veterinary specialty hospitals equipped with interventional radiology facilities is making stent placement more accessible, expanding treatment options for a wider range of patients. As veterinary medicine continues to shift toward less invasive and more patient-friendly treatment methods, the veterinary stents market is expected to experience substantial growth, with continuous improvements in stent design and procedural techniques enhancing long-term success rates.

SCOPE OF STUDY:

The report analyzes the Veterinary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Airway Stents, Urethral Stents, Vascular Stents, Other Stents); Animal Type (Dogs, Cats, Others); Material (Nitinol, Biodegradable Polymer); Application (Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions, Other Applications); End-Use (Veterinary Hospitals & Clinics, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

  • AccuPath Group Co., Ltd.
  • AbtVet (Stening Group)
  • Alibaba Group Holding Ltd.
  • Arthrex Vet Systems
  • Create Medic Co., Ltd.
  • Dextronix Animal Health
  • Infiniti Medical
  • M.I. Tech Co., Ltd.
  • NuMED For Children
  • TaeWoong Medical USA (VetSarang)
  • UltraVet Medical Devices LLC
  • VCA Animal Hospitals
  • VetMedUSA
  • VetStent
  • Medtronic
  • Boston Scientific
  • Cook Medical
  • Abbott Laboratories
  • Terumo Corporation
  • B. Braun Melsungen AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Veterinary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Interventional Veterinary Procedures Drive Adoption of Minimally Invasive Stenting Solutions
    • Rising Incidence of Tracheal Collapse and Urethral Obstruction Throws the Spotlight On Specialty Stent Applications
    • Integration of Fluoroscopy and Endoscopy with Stenting Enhances Procedural Precision and Expands Use Cases
    • Increasing Pet Longevity Spurs Demand for Long-Term Palliative Solutions Such as Stents
    • Customization Capabilities in Stent Design Expands Addressable Market Opportunity for Specialized Animal Anatomy
    • Technological Innovations in Self-Expanding and Bioabsorbable Stents Propel Product Differentiation
    • Growing Popularity of Specialty Veterinary Hospitals Strengthens Business Case for Advanced Interventional Devices
    • Surge in Companion Animal Surgeries Drives Demand for Post-Operative Support Devices Including Stents
    • Improvements in Stent Material Science Generate Opportunities for Lightweight and Flexible Implant Solutions
    • Veterinary Oncologic Applications Drive Adoption of Stents for Palliative Care in Obstructive Tumors
    • Integration of 3D Printing Technology in Stent Manufacturing Spurs Rapid Prototyping and Personalized Implants
    • Collaborations Between Academic Veterinary Centers and Manufacturers Accelerate Clinical Validation of Novel Stent Designs
    • Expansion of Veterinary Training in Interventional Radiology and Cardiology Drives Procedural Uptake
    • Increase in Feline and Small Dog Urethral Disorders Propels Growth in Miniature and Species-Specific Stent Offerings
    • Regulatory Approvals and Clinical Trials for Veterinary-Specific Stents Strengthen Market Accessibility and Trust
    • Rising Pet Insurance Coverage for Advanced Procedures Encourages Use of Premium Interventional Solutions
    • Market Consolidation and Strategic Acquisitions in Veterinary Devices Expand Distribution of Niche Products like Stents
    • Increased Emphasis on Quality of Life Outcomes in Geriatric Pets Spurs Adoption of Non-Surgical Interventions
    • Surge in Cross-Species Application Research Generates Demand for Flexible, Multi-Species Stenting Platforms
    • Development of Antimicrobial and Drug-Eluting Veterinary Stents Sustains Innovation-Driven Market Growth
    • Veterinary Cardiology and Urology Advancements Propel Usage of Specialized Intraluminal Devices Across Animal Health Practices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Stents Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Veterinary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Airway Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Airway Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Urethral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Urethral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Stent Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Stent Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Airway Collapse by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Airway Collapse by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Urinary Tract Obstructions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Urinary Tract Obstructions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Vascular Obstructions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Vascular Obstructions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Veterinary Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Veterinary Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Dogs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Dogs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cats by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Cats by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Nitinol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Nitinol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biodegradable Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Biodegradable Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • JAPAN
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • CHINA
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • EUROPE
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Veterinary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • FRANCE
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • GERMANY
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • UNITED KINGDOM
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Veterinary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Stent Type - Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Veterinary Stents by Stent Type - Percentage Breakdown of Value Sales for Airway Stents, Urethral Stents, Vascular Stents and Other Stent Types for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Application - Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Veterinary Stents by Application - Percentage Breakdown of Value Sales for Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions and Other Applications for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by End-Use - Veterinary Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Veterinary Stents by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals & Clinics and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Animal Type - Dogs, Cats and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Veterinary Stents by Animal Type - Percentage Breakdown of Value Sales for Dogs, Cats and Other Animal Types for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Veterinary Stents by Material - Nitinol and Biodegradable Polymer - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Veterinary Stents by Material - Percentage Breakdown of Value Sales for Nitinol and Biodegradable Polymer for the Years 2025 & 2030

IV. COMPETITION